Regulation of Autophagy-Related Protein and Cell Differentiation by High Mobility Group Box 1 Protein in Adipocytes

被引:10
|
作者
Feng, Huanhuan [1 ,2 ]
Yu, Lili [1 ,2 ]
Zhang, Guojun [1 ,2 ]
Liu, Guoyan [1 ,2 ]
Yang, Can [1 ,2 ]
Wang, Hui [2 ]
Song, Xiangfeng [1 ,2 ]
机构
[1] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan Province, Peoples R China
[2] Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan Province, Peoples R China
基金
中国国家自然科学基金;
关键词
INSULIN-RESISTANCE; OBESITY; INFLAMMATION; CANCER; HMGB1; METABOLISM; DYSFUNCTION; FEATURES; DISEASE; STRESS;
D O I
10.1155/2016/1936386
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
High mobility group box 1 protein (HMGB1) is a molecule related to the development of inflammation. Autophagy is vital to maintain cellular homeostasis and protect against inflammation of adipocyte injury. Our recent work focused on the relationship of HMGB1 and autophagy in 3T3-L1 cells. In vivo experimental results showed that, compared with the normal-diet group, the high-fat diet mice displayed an increase in adipocyte size in the epididymal adipose tissues. The expression levels of HMGB1 and LC3II also increased in epididymal adipose tissues in high-fat diet group compared to the normal-diet mice. The in vitro results indicated that HMGB1 protein treatment increased LC3II formation in 3T3-L1 preadipocytes in contrast to that in the control group. Furthermore, LC3II formation was inhibited through HMGB1 knockdown by siRNA. Treatment with the HMGB1 protein enhanced LC3II expression after 2 and 4 days but decreased the expression after 8 and 10 days among various differentiation stages of adipocytes. By contrast, FABP4 expression decreased on the fourth day and increased on the eighth day. Hence, the HMGB1 protein modulated autophagy-related proteins and lipid-metabolism-related genes in adipocytes and could be a new target for treatment of obesity and related metabolic diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Unraveling the role of high mobility group box protein 1 in severe trauma
    Edward Abraham
    [J]. Critical Care, 13
  • [22] High mobility group box 1 protein induction by Mycobacterium Bovis BCG
    Hofner, Peter
    Seprenyi, Gyoergy
    Miczak, Andras
    Buzas, Krisztina
    Gyulai, Zsofia
    Medzihradszky, Katalin F.
    Rouhiainen, Ari
    Rauvala, Heikki
    Mandi, Yvette
    [J]. MEDIATORS OF INFLAMMATION, 2007, 2007
  • [23] High Mobility Group Box Protein-1 in Experimental Autoimmune Uveoretinitis
    Watanabe, Takayo
    Keino, Hiroshi
    Sato, Yasuhiko
    Kudo, Akihiko
    Kawakami, Hayato
    Okada, Annabelle A.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (05) : 2283 - 2290
  • [24] The role of high mobility group box-1 protein in severe sepsis
    Sunden-Cullberg, Jonas
    Norrby-Teglund, Anna
    Treutiger, Carl Johan
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (03) : 231 - 236
  • [25] Unraveling the role of high mobility group box protein 1 in severe trauma
    Abraham, Edward
    [J]. CRITICAL CARE, 2009, 13 (06):
  • [26] The role of high-mobility group protein box 1 in lung cancer
    Wu, Xiao-Jin
    Chen, Yuan-Yuan
    Gong, Chan-Chan
    Pei, Dong-Sheng
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (08) : 6354 - 6365
  • [27] The role of high mobility group box 1 protein in acute cerebrovascular diseases
    Mu, Shu-Wen
    Dang, Yuan
    Wang, Shou-Sen
    Gu, Jian-Jun
    [J]. BIOMEDICAL REPORTS, 2018, 9 (03) : 191 - 197
  • [28] The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis
    Chen, Yu
    Sun, Wei
    Gao, Rongfen
    Su, Yuying
    Umehara, Hisanori
    Dong, Lingli
    Gong, Feili
    [J]. RHEUMATOLOGY, 2013, 52 (10) : 1739 - 1747
  • [29] Identification of lipopolysaccharide binding site on High Mobility Group Box 1 Protein
    Youn, Ju Ho
    Shin, Jeon-Soo
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182
  • [30] High mobility group box chromosomal protein 1 in patients with renal diseases
    Sato, Fumihiko
    Maruyama, Shoichi
    Hayashi, Hiroki
    Sakamoto, Izumi
    Yamada, Shingo
    Uchimura, Tomonori
    Morita, Yoshiki
    Ito, Yasuhiko
    Yuzawa, Yukio
    Maruyama, Ikuro
    Matsuo, Seiichi
    [J]. NEPHRON CLINICAL PRACTICE, 2008, 108 (03): : C194 - C201